Equity Overview
Price & Market Data
Price: $12.10
Daily Change: +$0.15 / 1.24%
Daily Range: $12.10 - $12.10
Market Cap: $437,761,664
Daily Volume: 252
Performance Metrics
1 Week: 39.12%
1 Month: 12.74%
3 Months: 88.19%
6 Months: 283.0%
1 Year: 856.0%
YTD: 90.29%
Company Details
Employees: 61
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.